When ultrasound bursts are combined with a circulating microbubble agent, a temporary disruption in the blood-brain barrier (BBB) is induced that lasts for several hours. This procedure, when combined with ultra- sound devices that can accurately and safely focus an ultrasound beam through the intact skull, has a great potential as a completely noninvasive and targeted method to deliver drugs to the brain. Numerous animal studies have shown that this method does not produce any significant damage to the brain and can also in- crease the permeability of tumor blood vessels. While this technology has potential for a wide range of brain disorders, we think it is likely that initial tests of the method will be in brain tumors. Brain metastases, for which there may already exist drugs that are effective outside the brain, may be a good target to test clinical efficacy. This project aims to perform studies that are needed before we can start a clinical trial to test the efficacy of BBB and blood-tumor barrier disruption for targeted drug delivery in brain tumors. We are aiming to be ready to test the efficacy of this technique in breast cancer brain metastases patients, and we have tai- lored the research around that application. We will perform three studies that evaluate safety and effective- ness of focused ultrasound induced BBB disruption under scenarios we will encounter in a clinical trial. First, we will evaluate the relative efficacy of the two currently-approved agents for treating HER2-positive breast cancer, trastuzumab (Herceptin(R)) and lapatinib (Tykerb(R)). Next, we will evaluate the safety and effectiveness of inducing BBB disruption in the brain and in brain tumors after radiation therapy, a scenario that we expect to encounter in patients. Finally, we will test the safety of repeatedly disrupting extensive volumes in the brain in nonhuman primates using a clinical MRI-guided transcranial focused ultrasound system. These is- sues all need to be resolved before initiating clinical trials. At the end of the grant, we expect to have the data necessary to begin clinical trials on the efficacy of this promising image-guided targeted drug delivery method.
; Ineffective drug delivery caused by the blood-brain barrier, limited permeability of tumor blood vessels, and other factors are thought to lead to the poor outcomes of patients with breast cancer metastases in the brain. Focused ultrasound, when combined with a microbubble agent, offers a noninvasive method to get around these barriers and deliver effective doses of drugs to the brain and to brain tumors. Here we will perform the work needed before we can begin clinical trials evaluating the efficacy of this method.
|Arvanitis, Costas D; Askoxylakis, Vasileios; Guo, Yutong et al. (2018) Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A 115:E8717-E8726|
|Harary, Maya; Essayed, Walid I; Valdes, Pablo A et al. (2018) Volumetric analysis of magnetic resonance-guided focused ultrasound thalamotomy lesions. Neurosurg Focus 44:E6|
|Todd, Nick; Zhang, Yongzhi; Arcaro, Michael et al. (2018) Focused ultrasound induced opening of the blood-brain barrier disrupts inter-hemispheric resting state functional connectivity in the rat brain. Neuroimage 178:414-422|
|Crake, Calum; Brinker, Spencer T; Coviello, Christian M et al. (2018) A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device. Phys Med Biol 63:065008|
|Brinker, Spencer T; Crake, Calum; Ives, John R et al. (2018) Scalp sensor for simultaneous acoustic emission detection and electroencephalography during transcranial ultrasound. Phys Med Biol 63:155017|
|Sun, Tao; Zhang, Yongzhi; Power, Chanikarn et al. (2017) Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci U S A 114:E10281-E10290|
|Arvanitis, Costas D; Crake, Calum; McDannold, Nathan et al. (2017) Passive Acoustic Mapping with the Angular Spectrum Method. IEEE Trans Med Imaging 36:983-993|
|Sai Chun Tang; McDannold, Nathan J; Vaninetti, Michael (2017) A wireless batteryless implantable radiofrequency lesioning device powered by intermediate-range segmented coil transmitter. Conf Proc IEEE Eng Med Biol Soc 2017:1966-1969|
|Taylor, Erik N; Ding, Yao; Zhu, Shan et al. (2017) Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma. Oncotarget 8:41815-41826|
|Aryal, Muna; Fischer, Krisztina; Gentile, Caroline et al. (2017) Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles. PLoS One 12:e0166061|
Showing the most recent 10 out of 28 publications